RNI:JSEReinet Investments S.C.A. Analysis
Data as of 2026-03-12 - not real-time
ZAC 53,434.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
RNI is trading at ZAc 53,434, below its 20‑day (ZAc 54,607) and 50‑day (ZAc 55,784) simple moving averages, with a bearish MACD histogram and an RSI of 42.6, indicating short‑term momentum weakness.
Fundamentally, the stock appears overvalued – its trailing PE of 38.1 is more than double the industry average of 16.6, and its price‑to‑book of 77x dwarfs the book value per share of ZAc 693. However, the dividend yield of 1.41% is backed by a modest 50% payout ratio, suggesting the dividend is sustainable. The low beta (~0.11) points to limited market‑wide volatility, though the 30‑day volatility of 21.9% and a max drawdown of 16% signal moderate price swings. Overall, the technical picture is bearish, valuation metrics are stretched, but the dividend provides a modest defensive cushion.
Fundamentally, the stock appears overvalued – its trailing PE of 38.1 is more than double the industry average of 16.6, and its price‑to‑book of 77x dwarfs the book value per share of ZAc 693. However, the dividend yield of 1.41% is backed by a modest 50% payout ratio, suggesting the dividend is sustainable. The low beta (~0.11) points to limited market‑wide volatility, though the 30‑day volatility of 21.9% and a max drawdown of 16% signal moderate price swings. Overall, the technical picture is bearish, valuation metrics are stretched, but the dividend provides a modest defensive cushion.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below key moving averages
- Bearish MACD and RSI below 50
- Overvaluation relative to peers
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential mean‑reversion to SMA levels
- Sustainable dividend offering income
- Continued valuation pressure
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Flat revenue growth and declining forward EPS
- Persistently high PE and PB ratios
- Limited upside without a catalyst for valuation compression
Key Metrics & Analysis
Financial Health
Profit Margin98.54%
P/E Ratio38.1
ROE2.04%
ROA1.27%
P/B Ratio77.1
Op. Cash FlowZAC67.0M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI42.6
SupportZAC 53,080.00
ResistanceZAC 56,343.00
MA 20ZAC 54,607.75
MA 50ZAC 55,783.30
MA 200ZAC 53,771.31
MACDBearish
VolumeIncreasing
Fear & Greed Index78.16
Valuation
Fair ValueZAC 341.71
GradeOvervalued
TypeValue
Dividend Yield1.41%
Risk Assessment
Beta0.11
Volatility21.94%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.